Literature DB >> 6989495

Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration.

N T Kimura, S Taniguchi, K Aoki, T Baba.   

Abstract

A strain of domestic bacteria, Bifidobacterium bifidum (Lac B), which is nonpathogenic and anerobic, selectively localized and proliferated in several types of mouse tumors following i.v. administration. None of the same bacilli could be detected in the tissues of healthy organs such as the liver, spleen, kidney, lung, blood, bone marrow, and muscle 48 or 96 hr after i.v. administration into tumor-bearing mice. Proliferation of Lac B in the tumor was artifically stimulated by i.p. administration of DDD-H-2s mice of a synthesized disaccharide, lactulose (4-O-beta-D-galactopyranosyl-D-fructofuranose), a sugar which is not metabolized by mammalian tissue cells. Lac B, which survices and proliferates selectively in the tumor following i.v. administration into the tumor-bearing host, should aid in diagnosis and selective therapy for cancer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989495

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Can engineered bacteria help control cancer?

Authors:  R K Jain; N S Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model.

Authors:  Masashi Momiyama; Ming Zhao; Hiroaki Kimura; Benjamin Tran; Takashi Chishima; Michael Bouvet; Itaru Endo; Robert M Hoffman
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

Review 3.  Imaging for infection: from visualization of inflammation to visualization of microbes.

Authors:  Justin Ady; Yuman Fong
Journal:  Surg Infect (Larchmt)       Date:  2014-12       Impact factor: 2.150

Review 4.  Potent and tumor specific: arming bacteria with therapeutic proteins.

Authors:  Nele Van Dessel; Charles A Swofford; Neil S Forbes
Journal:  Ther Deliv       Date:  2015-03

5.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

6.  Attenuated Salmonella typhimurium carrying shRNA-expressing vectors elicit RNA interference in murine bladder tumors.

Authors:  Nan Yang; Sheng-hua Li; Yun-zhe Lü; Li-shan Chen; Da-ming Ren
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

7.  Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer.

Authors:  Clinton Yam; Ming Zhao; Katsuhiro Hayashi; Huaiyu Ma; Hiroyuki Kishimoto; Michele McElroy; Michael Bouvet; Robert M Hoffman
Journal:  J Surg Res       Date:  2009-03-31       Impact factor: 2.192

8.  Therapeutic efficacy of Bifidobacterium longum-mediated human interleukin-2 with endostatin or TRAIL in transplanted tumors in mice.

Authors:  Yan Yin; Lei Kou; Jian-Jun Wang; Gen-Xing Xu
Journal:  Exp Ther Med       Date:  2011-12-19       Impact factor: 2.447

9.  Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium.

Authors:  H Kimura; L Zhang; M Zhao; K Hayashi; H Tsuchiya; K Tomita; M Bouvet; J Wessels; R M Hoffman
Journal:  Cell Prolif       Date:  2009-11-18       Impact factor: 6.831

Review 10.  Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management.

Authors:  Guoying Ni; Tianfang Wang; Lin Yang; Yuejian Wang; Xiaosong Liu; Ming Q Wei
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.